1. Home
  2. BLW vs CATX Comparison

BLW vs CATX Comparison

Compare BLW & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock Limited Duration Income Trust

BLW

Blackrock Limited Duration Income Trust

HOLD

Current Price

$12.34

Market Cap

499.1M

ML Signal

HOLD

Logo Perspective Therapeutics Inc.

CATX

Perspective Therapeutics Inc.

HOLD

Current Price

$3.75

Market Cap

497.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLW
CATX
Founded
N/A
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
499.1M
497.9M
IPO Year
2003
2018

Fundamental Metrics

Financial Performance
Metric
BLW
CATX
Price
$12.34
$3.75
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$12.11
AVG Volume (30 Days)
113.2K
1.5M
Earning Date
01-01-0001
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.06
$1.96
52 Week High
$14.28
$6.16

Technical Indicators

Market Signals
Indicator
BLW
CATX
Relative Strength Index (RSI) 26.27 41.06
Support Level $12.06 $3.17
Resistance Level $12.92 $3.80
Average True Range (ATR) 0.15 0.27
MACD -0.04 0.01
Stochastic Oscillator 11.11 33.09

Price Performance

Historical Comparison
BLW
CATX

About BLW Blackrock Limited Duration Income Trust

Blackrock Ltd Duration Income Trust is a closed-end management investment company. Its investment objective is to provide current income and capital appreciation.

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Share on Social Networks: